 |
N’-(7-Chloroquinolin-4-yl)-N,N-diethyl-propane-1,3-diamine |
|---|---|
| Trade Name | |
| Orphan Indication | Malaria |
| USA Market Approval | USA |
| USA Designation Date | 2015-10-29 00:00:00 |
| Sponsor | Donald J. Krogstad, MD;1430 Tulane Ave., #8317, J.B. Johnson Building;New Orleans, Louisiana, 70112 |
